R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma
R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma
Not yet recruiting · NCT07764601 · Registry updated 2026-08-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, primary central nervous system lymphoma | Not yet recruiting | Not applicable | 2026-08-14 | NCT07764601 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Wei Xu | 3 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Nanjing Medical University | Nanjing | China | 23 |
| The First People's Hospital of Changzhou | Changzhou | China | 6 |
| The First People's Hospital of Huai'an | Huai'an | China | 2 |
| Wuxi People's Hospital | Wuxi | China | 3 |
| Yixing People's Hospital | Yixing | China | 1 |